Nebius closes Eigen AI acquisition; inference technology added but core execution risks unchanged

What happened

Nebius completed its acquisition of Eigen AI, an inference and model optimization specialist, for an undisclosed sum after regulatory clearance. While the deal strengthens Nebius's AI software stack, it does not alter the company's primary value driver: converting contracted power into delivered GPU capacity under hyperscaler tranches. The Q1'26 revenue of $399M and $2.26B operating cash flow from customer advances underscore momentum, but the WAIT rating persists due to execution risk on the 800MW–1GW connected power target and potential SLA penalties. Management's financing cadence remains a watchpoint, with $9.3B cash on hand but no ATM usage to date. Eigen AI is a bolt-on enhancement, not a thesis-changer.

Implication

For investors, the Eigen AI acquisition is a modest positive for Nebius's inference capabilities but does not shift the fundamental underwriting question of whether the company can deliver connected power and avoid service credits. The stock's valuation at ~$250 already prices in flawless execution, so near-term upside requires proof of milestone delivery, not bolt-on M&A. The acquisition likely consumed a small portion of the $9.3B cash balance, but any incremental dilution or ATM usage would be a negative signal. Long-term holders should monitor Q3 capacity disclosures and tranche delivery timelines, as these remain decisive. The thesis delta is negligible; the core WAIT call with a 3-6 month re-assessment window remains appropriate.

Thesis delta

The Eigen AI acquisition adds inference optimization skills but does not change Nebius's primary risks around power activation, tranche delivery, and financing discipline. The WAIT rating and $200-$300 entry/trim bands remain unchanged. No material shift to the thesis.